An obsevational study to compare the effects of anti allergic eyedrops in patients of allergic conjunctivitis.
Phase 4
Completed
- Conditions
- Health Condition 1: H108- Other conjunctivitisHealth Condition 2: null- vernal keratoconjunctivitis
- Registration Number
- CTRI/2018/03/012788
- Lead Sponsor
- All India Institute of Medical SciencesRishikesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
patients with a clinical diagnosis of vernal keratoconjunctivitis.
patients of either gender > 5 years.
patients should be willing to consent for all required study visits and follow instructions from study investigators.
Exclusion Criteria
Patients who are in active stage of any other ocular inflammatory disease besides VKC
Presence of glaucoma, uveitis.
Patients on any oral or topical steroids.
Pregnant or lactating women.
Presence of systemic diseases other than co existing allergic rhinitis, asthma and atopic dermatitis
Any documented H/O hypersensitivity to the said drugs.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Resolution of signs and symptoms in patients of vernal keratoconjunctivitis treated with dual acting antihistamines and mast cell stabilisers.Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Resolution of signs and symptoms in patients of vernal keratoconjunctivitis treated with dual acting antihistamines and mast cell stabilisers.Timepoint: 2 Weeks